Identification of novel alternative splice variants of the BCL2L12 gene in human cancer cells using next-generation sequencing methodology.


The next-generation sequencing (NGS) technology has enabled genome-wide studies, providing massively parallel DNA sequencing. NGS applications constitute a revolution in molecular biology and genetics and have already paved new ways in cancer research. BCL2L12 is an apoptosis-related gene, previously cloned from members of our research group. Like most… (More)
DOI: 10.1016/j.canlet.2016.01.019


8 Figures and Tables